Kenneth L Londoner

Kenneth L Londoner serves as the CEO of BioSig Technologies. This is a medical device company founded by Londoner in February 2009.

BioSig has developed a system to improve Atrial Fibrillation and Ventricular Tachycardia, called PURE EP. This is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system.

Additionally, Londoner serves as the Managing Partner of Endicott Management Partners, LLC, a company that assists emerging growth companies in their corporate development and investing needs.

Previously, Kenneth L Londoner was the executive vice president of the Silicon Valley-based cardiac software company, NewCardio, Inc. He has held this position from April 2007 to October 2009.

Kenneth L Londoner worked at Alliqua BioMedical, Inc. as the Director and the architect for the turnaround from May 2012 to March 2014.

Londoner co-founded a port security and logistics company based in Charleston, South Carolina, called Safe Ports Holdings.

In 1996 he founded Red Coat Capital Management and served as its managing partner. Red Coat Capital Management is a hedge fund has grown from its initial base of $ 2 million in assets to a peak of $ 1.1 billion.

At the present moment, Londoner is working on commercialization of the PURE EP System, which was approved by FDA.

Read about Londoner's work at his profile on MyScienceWork.